Skip to main content

Young Researchers Forum - Identify and Characterize the Cancer Stemness Role of Maelstrom in Hepatocellular Carcinoma

Abstract: 

Hepatocellular carcinoma (HCC) is the fourth most common type of cancer in Hong Kong SAR and ranks as the third leading mortality rate of cancer type worldwide. A wise strategy for better understanding the enrolled molecular mechanisms in HCC progression, which is needed to discover novel diagnostic markers and therapeutic targets. According to an analysis of our RNA sequence data of three paired HCC and non-tumor tissue samples, human maelstrom (MAEL) gene was chosen to study. Our preliminary data suggested that MAEL frequently upregulated in HCC patients, associated with tumor size, adjacent organ invasion, tumor recurrence, and worse overall survival rate. The previous study demonstrated that MAEL promoted HCC cells proliferation and metastasis as well as upregulating several stemness-related genes expression in mRNA level through AKT/GSK3β/Snail signaling pathways. However, the cancer stemness regulating ability and downstream targets of MAEL is still not well studied. Therefore, this project would focus on revealing novel targets of MAEL and further investigate the unique role in regulating cancer stemness. We analyzed MAEL expression and survival data in TCGA LIHC cohort, the results were consistent with our previous findings. We found that overexpress MAEL could not only promote the ability of HCC cell proliferation and mobility in vitro but also increase the proportion of CD133+ cells, self-renew and sorafenib resistant ability. Moreover, knockout MAEL showed reverse results in PLC8024 cell line inhibited these functions. We applied next-generation sequencing (NGS) technology to compare with vector group and MAEL transfected group cells which revealed that MAEL enrolled in the extracellular matrix (ECM) receptor interaction pathways mediated cancer stem cell marker CD44 expression. This finding confirmed by Q-PCR, western blots and flow cytometry. Taken together, these data suggest MAEL could promote HCC cells proliferation, metastasis as well as increasing stem cell features.

Speaker Biography: 
Charon Shi graduated from Capital Medical University in 2015 as the major of Medical Laboratory Tests (MLT). After finished the internship in Beijing Anzhen Hospital, Charon Shi joined in Dept. Clinical Oncology, HKU as research in October 2015. In September 2017, Charon Shi began his postgraduate study in the same laboratory with the supervision of Prof. Dora Kwong and Prof. XY Guan. Our laboratory is focused on discovering novel cancer-related genes and mir-RNAs in gastric cancer (GC), hepatocellular carcinomas (HCC), esophageal carcinomas (ESCC) and nasopharyngeal carcinoma (NPC). Charon Shi current study is supported by the Health and Medical Research Fund.

Comments

Popular posts from this blog

Past Conference Report - Cancer Research

With great support from our Collaborators and Organizing Committee, PULSUS Conferences successfully completed the “Cancer 2018” which was held at Edinburgh, Scotland on March 26-27, 2018. We would like to thank our Keynote Speakers for the conference - Hiroshi Kobayashi , Chiba University, Japan, William T. Beck , University of Illinois, USA, Shalini Gupta , King George Medical College, India, Antonio Gomez-Munoz , University Of The Basque Country, Spain, Barbara DeVivo , Westmont University, USA. for their support in making this event a great success. We would like to extend our thanks to our collaborators “ Sudanese Medical Research Association ”, “ Uganda Cancer Society ” and “ Pharmaceutical Society of Uganda ” for their constant support. It wouldn’t have been possible without the support of our Media Partners who helped us in promoting this event. We thank our Media partners for their support in helping us reach a greater audience. We also would like to thank all o...

Poster Presentation - The Immunogradient of CD8+ cell density in the tumour-stroma interface zone predicts overall survival of patients with hormone receptor-positive invasive ductal breast carcinoma

Abstract Statement of the Problem: Tumour-infiltrating lymphocytes (TIL) are associated with better prognosis in triple-negative and HER2-positive breast cancer (1, 2), and TIL assessment by digital image analysis (DIA) has been successfully implemented in colorectal and other cancers (3). However, results in hormone receptor-positive breast cancer (HRBC) based on manual scoring remain contradictory (2). Here we used an automated DIA method to extract the prognostic value of novel Immunogradient indicators in CD8+ cell density profiles in HRBC. Methodology & Theoretical Orientation: Surgically excised HRBC samples from 102 patients were immunohistochemically stained for CD8, digitized and analyzed by the HALO™ platform. The DIA data were subsampled by a hexagonal grid and explicit rules were then used to extract the tumor-stroma interface zone (IZ) and compute novel Immunogradient indicators from TIL density profiles across the IZ. The prognostic value was evaluated by sur...

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise...